Eurofins Scientific Announce Agfirst Bay of Plenty Acquisition
Eurofins Scientific has announced the acquisition of Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand. Agfirst Bay of Plenty provides independent kiwifruit maturation sampling and testing services across two facilities in the Bay of Plenty region of New Zealand.
Eurofins Scientific (Luxembourg City, Luxembourg) has announced the acquisition of Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand. Agfirst Bay of Plenty provides independent kiwifruit maturation sampling and testing services across two facilities in the Bay of Plenty region of New Zealand.
The kiwifruit is New Zealand’s leading horticultural export and the industry is experiencing a period of significant growth. The company is situated within the Bay of Plenty region, which represents approximately 80% of New Zealand’s kiwifruit crop, further highlighting its importance economically.
“Agfirst Bay of Plenty expands Eurofins food testing offering in New Zealand and reinforces our footprint in the Asia-Pacific region. This acquisition is consistent with our strategy of building leading positions in niche areas in the testing market, to ensure deepest expertise in a wide range of markets. We look forward to providing AgFirst Bay of Plenty’s clients with access to the full range of services and capabilities of the Eurofins Group,” said Dr. Gilles Martin, Eurofins CEO.
For more information please visit www.eurofins.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
